Augustinos Nicholas's Form 4 filing
Dexcom Inc (DXCM) · filed Jun 17, 2025
- Accession no.
- 0001093557-25-000212
- Filed
- Jun 17, 2025
- Trade date
- Jun 13-16, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $517.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Augustinos NicholasCIK 0001238485 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | Common Stock | SSaleDisposed | −2,618 | $81.69 | −$213,864.42 | 37,083 | Indirect | |
| Jun 16, 2025 | Common Stock | SSaleDisposed | −3,672 | $82.80 | −$304,041.6 | 33,411 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Exhibit 24 - Power of Attorney